Events › Healthcare & MedTech
Healthcare & MedTech
The COPD Drug Development Summit 2026 is a specialized B2B forum focusing on accelerating drug development, clinical trials, and translational science for Chronic Obstructive Pulmonary Disease.
Attendees: Discovery, translational, clinical, and regulatory leaders from pharma and biotech
Filter this event to your ICP.
A curated group of solution providers here. You probably care about 20–30. Tell us your ICP, we'll find them.
Request intelligence →Delivery within 24 hours · $1,250
Organizer
Hanson WadePE-backed · London, United Kingdom · Founded 2008
Hanson Wade is a global conference organizer and market intelligence provider focused primarily on the life sciences and biopharma sectors.
Exhibitor list
12 companies are exhibiting at COPD Drug Development Summit. The full list is shown below.
Also exhibits at 5th World ADC Summit South Korea
Why people attend
Discovery, translational, clinical, and regulatory leaders from pharma and biotech attend to learn about novel targets and strategies to de-risk development and accelerate approvals.
Exhibitor categories
Speakers
17 speakers at COPD Drug Development Summit
Tenured Full Professor, Department of Pediatrics, Faculty of Medicine, McGill University; Director, Division of Pediatric Respiratory Medicine and Director, Pediatric Cystic Fibrosis Clinic…
Head of Clinical Imaging, Early Clinical Development, Respiratory & Immunology at AstraZeneca, with extensive experience integrating medical imaging into clinical trials. Brings deep expertise in…
Dr. George R. Washko, Jr. is a respiratory physician at Mass General Brigham (MGB), the associate chief and director of research operations for the division of pulmonary and critical care medicine…
Clinical Imaging Scientist with over two decades of expertise in optimizing CT, MRI, and ultrasound protocols to minimize confounding factors, enhancing biomarker identification…
Dr. Pilon is a multi-functional executive with 25 years of broad-based entrepreneurial experience in the biopharmaceutical industry, including project management, fundraising, team building…
Dr. Jim Wu is founder and CEO of Shanghai Ark Biopharmaceutical Co. (ArkBio). ArkBio is a commercial stage biotech company, focusing on R&D in the respiratory and lung disease areas…
Dr. Rahmo earned his degree in Biochemistry from the Swiss Federal Institute of Technology in Zurich in 1988, before completing his PhD at the University of Southern California in Los Angeles in 1994.
Dr. Barry Quart brings over 30 years of extensive experience serving in leadership positions in biotechnology and pharmaceutical companies and developing innovative pharmaceutical products.
Chris joined Kinaset in June 2022, bringing more than 20 years of experience in early and late phase clinical development across inhaled, oral, and biologic therapies. He has led over 25 Phase 2–4…
Also speaking at 11th Microbiome Movement USA Summit
Also speaking at Bits & Pretzels 2026, embedded world Exhibition&Conference, 6th mRNA-Based Therapeutics Summit
+ 1 more speakers at this event.
More Healthcare & MedTech events
Frequently asked questions